Applied Nutrition is poised for a significant public offering on the London Stock Exchange, aimed at raising £500m.
- The Liverpool-based company has demonstrated substantial growth over the past year, expanding its market reach globally.
- The IPO will include shares sold by current shareholders and targets both institutional and retail investors.
- Recent leadership enhancements include AJ Bell founder Andy Bell as chair and other strategic non-executive directors.
- London Stock Exchange listings have declined, marking this IPO as potentially one of the most notable this year.
Applied Nutrition, a Liverpool-based performance supplement manufacturer, is preparing for a £500m initial public offering (IPO) on the London Stock Exchange. The company has expanded its market presence to over 80 countries and has shown remarkable growth in the 12 months leading up to July.
The IPO plan, revealed in August, is now confirmed to occur this month. The offer involves the sale of existing shares by current shareholders and targets institutional investors in the UK alongside retail investors through the Retail Book platform. The company aims to achieve a free float of at least 25% post-IPO.
Strengthening its senior leadership in readiness for the listing, the company appointed Andy Bell, founder of AJ Bell, as chair in February. Additionally, Tony Buffin and Marnie Millard joined as non-executive directors, bringing their extensive experience to the board.
As the London Stock Exchange struggles to attract new listings—only 23 in the previous year compared to 45 in 2022 and 119 in 2021—Applied Nutrition’s IPO stands out as a significant event. The company’s public listing is anticipated to be one of the most notable on the exchange this year.
Applied Nutrition’s upcoming IPO is a key event for both the company and the London Stock Exchange this year.
